The famous saying goes ”If you can’t explain your research to your family, then you don’t understand it yourself.” The past year has taught us that scientific communication and public engagement have never been more important. Across the planet, the leading medical experts have done their best to brief the public on the latest news…
Mobilise-D and IDEA-FAST are pleased to announce the creation of the Digital Health Catalyst (DHC). Mobilise-D is working on digital mobility assessment in chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), multiple sclerosis (MS) and recovery from proximal femoral fracture (PFF). IDEA-FAST is working to identify digital endpoints to assess fatigue, sleep disturbances and activities…
The dog’s best friends? Humans. The human’s best friend? Umm well, for many that seems to be the sofa – the buns’ best friend. This soft comfortable piece of fabric, encouraging you to be sedentary week in, week out. It becomes a better and better friend as the years go by, keeping you inactive. But did you know that inactivity…
All the constraints of the past year, the recurrent lockdowns, all the additional challenges we faced having to change our homes to home-offices and home-schooling, could easily have stopped us from our endeavour, but no! We managed to find our way and continue our research, our testing, and our engagement with patients. We invited one…
Last year was a turbulent and busy year for Mobilise-D in many ways, and this Public Newsletter highlights some of the most significant news from 2020. Read our Public Newsletter 2020 here.
From January 2021 onwards, Mobilise-D and IDEA-FAST, two ongoing EU Innovative Medicines Initiatives projects, will join forces to increase the impact and the benefits of digital health technologies developed by both projects.
This coming Friday Abolfazl Soltani, one of our Mobilisers from EPFL, Switzerland, will have the public defense of his PhD thesis. In his PhD work, Abolfazl has focused on accurate walking speed estimation and walking bout detection based on wrist-worn sensors. Although there are many different digital systems that can monitor gait in unsupervised free-living situations such as housekeeping, catching a bus, and shopping, they each have different advantages and disadvantages. One such system, the Global Navigation Satellite System (GNSS), can measure real-world gait speed accurately, but…
Image by Christian Mueller/Shutterstock Innovative Medicines Initiative (IMI) just published a great “One step closer” article about the Mobilise-D Consortium. “Mobilise-D’s letter of support from the EMA is not only a nod to the promise of their research – it shows how important it is to connect with regulators early.” Read the full article here!
Well known biomarkers such as blood pressure, respiration, temperature, pulse, and pain are frequently used by physicians and other health professionals to describe a patient’s health and disease status. In addition to these ‘signs of life’, there is another important aspect of people’s health and disease status, namely their mobility – how well they walk. Loss of physical mobility, such as reduced walking speed, is a significant feature of many health…
In the first year of Mobilise-D, we asked the European Medicines Agency (EMA) for qualification advice for Digital Mobility Outcomes (DMOs). EMA just published their letter of support that publicly endorses our initial stage in the wider objective of the Mobilise-D Consortium to pursue the qualification of Digital Mobility Outcomes (DMOs) as monitoring biomarkers of…